JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB256974

Human LGALS1 (Galectin 1) knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

LGALS1 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 171 bp deletion in exon 2.

View Alternative Names

14 kDa laminin-binding protein, 14 kDa lectin, Beta galactoside binding lectin, Beta-galactoside-binding lectin L-14-I, DKFZp686E23103, GALBP, Gal-1, Galaptin, Galectin, Galectin-1, HBL, HLBP14, HPL, L-14.5, L14, LEG1_HUMAN, LGALS 1, Lactose-binding lectin 1, Lect14, Lectin galactoside-binding soluble 1, Lgals1 lectin galactose binding soluble 1, MAPK activating protein MP12, Putative MAPK activating protein MP12, Putative MAPK-activating protein PM12, S-Lac lectin 1, beta galactoside binding protein

2 Images
Western blot - Human LGALS1 (Galectin 1) knockout HEK-293T cell lysate (AB256974)
  • WB

Lab

Western blot - Human LGALS1 (Galectin 1) knockout HEK-293T cell lysate (AB256974)

Lane 1 : Wild-type HEK-293T cell lysate (20µg)

Lane 2 : LGALS1 knockout HEK-293T cell lysate (20µg)

Lanes 1- 2 : Merged signal (red and green). Green - ab138513 observed at 15 kDa. Red - loading control ab8245 observed at 37 kDa.

ab138513 Anti-Galectin 1 antibody [EPR3206(2)] was shown to specifically react with Galectin 1 in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab266850 (knockout cell lysate ab256974) was used. Wild-type and Galectin 1 knockout samples were subjected to SDS-PAGE. ab138513 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Galectin 1 antibody [EPR3206(2)] (<a href='/en-us/products/primary-antibodies/galectin-1-antibody-epr32062-ab138513'>ab138513</a>) at 1/1000 dilution

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

LGALS1 knockout HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human LGALS1 (Galectin 1) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-lgals1-galectin-1-knockout-hek-293t-cell-line-ab266850'>ab266850</a>)

Predicted band size: 15 kDa

Observed band size: 15 kDa

false

Sanger Sequencing - Human LGALS1 (Galectin 1) knockout HEK-293T cell lysate (AB256974)
  • Sanger seq

Unknown

Sanger Sequencing - Human LGALS1 (Galectin 1) knockout HEK-293T cell lysate (AB256974)

Homozygous : 171 bp deletion in exon 2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 171 bp deletion in exon 2.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab256974-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human LGALS1 knockout HEK293T cell lysate", "number":"AB256974-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB256974-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
LGALS1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Galectin-1 also referred to as GAL1 or galectin 1 is a protein with a molecular mass of approximately 14.5 kDa. It belongs to a group called the beta-galactoside-binding lectins and is typically characterized by its distinct carbohydrate-recognition domain. Galectin-1 is expressed in a variety of tissues including muscle epithelial cells the nervous system and immune cells. In particular high expression levels are found in the placenta and the thymus indicating a role in development and immune function.
Biological function summary

This protein mediates a variety of cellular processes such as cell differentiation apoptosis and immune cell modulation. As a monomer galectin-1 binds specifically to beta-galactoside residues on the cell surface. It plays a significant role in regulation of cell signaling circuits affecting T-cell activation as well as macrophage function. The Galectin-1 protein does not commonly form complexes but can influence interactions of other proteins by binding to glycoproteins on the cell surface which can modulate signaling outcomes.

Pathways

The protein is actively involved in pathways related to cell-cell interactions and immune modulation. It interacts with pathways like Ras signaling which is fundamental in cell growth proliferation and survival. Through these pathways galectin-1 is closely related to other proteins including Ras and Raf which are critical in transmitting signals from the cell surface to the DNA in the nucleus affecting gene expression involved in apoptosis and autophagy.

Galectin-1 association with cancer progression and autoimmune diseases reflects its role in immune system regulation. High galectin-1 levels have been recorded in various tumors where the protein promotes tumor progression by supporting angiogenesis and suppressing immune response against cancer cells. In autoimmune disorders such as multiple sclerosis modulation of Galectin-1 levels can alter disease progression and the immune system’s behavior. The protein interacts with other key regulators like cytokines emphasizing its importance in immune-inflammatory pathways and potential as a therapeutic target.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com